Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2001-11-16
2004-12-07
Kerr, Kathleen (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
Reexamination Certificate
active
06828126
ABSTRACT:
FIELD OF THE INVENTION
The present invention provides recombinant methods and materials for producing polyketides by recombinant DNA technology. The invention relates to the fields of agriculture, animal husbandry, chemistry, medicinal chemistry, medicine, molecular biology, pharmacology, and veterinary technology.
BACKGROUND OF THE INVENTION
Oleandomycin (compound (
1
) of
FIG. 1
) is a member of the macrolide class of antibiotics. Macrolides are a large family of polyketide natural products which include erythromycin, spiramycin, FK506, and avermectin (see Katz et al.,
Polyketide synthesis: Prospects for hybrid antibiotics, Ann. Rev. Microbial.
47: 875-912, 1993; and Hopwood,
Genetic contributions to understanding polyketide synthases, Chem. Rev.
97: 2465-2497, 1997, each of which is incorporated herein by reference). The macrolactone core of oleandomycin, 8,8a-deoxyoleandolide (compound (
2
) of FIG.
1
), like those of other macrolides, is synthesized by a modular polyketide synthase (PKS; see FIG.
1
and Swan et al.,
Characterisation of a Streptomyces antibioticus gene encoding a type I polyketide synthase which has an unusual coding sequence, Molec. Gen. Genet.
242: 358-362, 1994, and U.S. patent application Ser. No. 09/428,517, filed Oct. 28, 1999, now U.S. Pat. No. 6,251,636 which issued on Jun. 26, 2001, each of which is incorporated herein by reference). 8,8a-deoxyoleandolide is structurally identical to the macrolactone precursor of erytbromycin, 6-deoxyerythronolide B (6-dEB, see compound (
3
) of FIG.
2
), with the exception of a C-13 methyl instead of the C-13 ethyl group of 6-dEB. Thus, 6-dEB is derived from condensations between a propionate starter unit and six methylmalonate extender units, and 8, 8a-deoxyoleandolide has an acetate starter unit.
The study of oleandomycin biosynthesis has been progressive over the past decade, due largely to the identification and sequencing of several biosynthetic and related genes by Salas and coworkers. Analysis of these gene sequences has revealed enzymes putatively involved in synthesis and attachment of the two deoxysugars, regulatory and antibiotic resistance genes, and a P-450 monooxygenase (see Rodriguez et al.,
A cytochrome P
450-
like gene possibly involved in oleandomycin biosynthesis by Streptomyces antibioticus, FEMS Microbiol. Lett.
127: 117-120, 1995; Olano et al.,
Analysis of a Streptomyces antibioticus chromosomal region involved in oleandomycin biosynthesis, which encodes two glycosyltransferases responsible for glycosylation of the macrolactone ring, Mol. Gen. Genet.
259: 299-308, 1998; and Quiros et al.,
Two glycosyltransferases and a glycosidase are involved in oleandomycin modification during its biosynthesis by Streptomyces antibioticus, Mol. Microbiol.
28: 1177-85, 1998, each of which is incorporated herein by reference). Thus, a single open reading frame (ORF) encoding a polypeptide subunit of a type I polyketide synthase was identified and, based on comparison to 6deoxerythronolide B synthase (DEBS), was hypothesized to encode the last two modules of the oleandomycin PKS (OlePKS; see Swan et al., supra). The cloning, characterization, and sequence determination of the other genes encoding the proteins of the OlePKS are described in PCT patent application No. PCT/US99/24478, incorporated herein by reference.
There remains, however, a need for additional methods and reagents to produce 8,8a-deoxyoleandolide, oleandomycin, and related compounds in heterologous host cells. The present invention meets these and other needs.
SUMMARY OF THE INVENTION
The gene cluster encoding the deoxyoleandolide polyketide synthase (OlePKS) was isolated from the oleandomycin producing strain
Streptomyces antibioticus.
Sequencing of the first two genes encoding OlePKS, together with the previously identified third gene revealed an overall genetic and protein architecture similar to that of the erythromycin gene cluster encoding the 6-deoxyerthronolide B synthase (DEBS) from
Saccharopolyspora erythraea.
When the entire OlePKS (10,487 amino acids) was expressed in the heterologous host
Streptomyces lividans,
it produced 8,8a-deoxyoleandolide (compound (
2
) of FIG.
1
), the aglycone precursor of oleandomycin. The P450 monooxygenase, OleP, involved in oleandomycin biosynthesis was co-expressed with DEBS in
S. lividans.
The production of 8,8a-dihydroxy-6-deoxyerythonolide B (compound (
6
) of
FIG. 2
) and other derivatives demonstrates that OleP is involved in the epoxidation pathway of oleandomycin biosynthesis. Further, a method of producing 8,8a-dihydroxy-6-deoxyerythonolide B or 8,8a-dihydroxyoleandolide comprising the heterologous expression of DEBS or Ole PKS, respectively, with OleP in
S. lividans
was developed. This heterologous expression system provides a means to produce these compounds, which can directly or after further modification be hydroxylated and glycosylated to provide useful macrolide antibiotics.
Thus, in one embodiment, the present invention provides a method for introducing one or more hydroxyl groups or an epoxide into a polyketide, which method comprises expressing a recombinant gene encoding a P450 monooxygenase in a host cell. In one embodiment, the P450 monooxygenase is not naturally expressed by the host cell. In another embodiment, neither the P450 monooxygenase nor the polyketide is naturally expressed by the host cell. In a preferred embodiment, the host cell is a Streptomyces host cell. In another preferred embodiment, the P450 monooxygenase is OleP. In another preferred embodiment, the polyketide synthase is 6-deoxverythronolide B synthase or 8,8a-deoxyoleandolide synthase.
REFERENCES:
patent: 2757123 (1956-07-01), Sobin et al.
patent: 5672491 (1997-09-01), Khosla et al.
patent: 5712146 (1998-01-01), Khosla et al.
patent: 5962290 (1999-10-01), Khosla et al.
patent: 6004787 (1999-12-01), Katz et al.
patent: 6033883 (2000-03-01), Barr et al.
patent: 6063561 (2000-05-01), Katz et al.
patent: 6066721 (2000-05-01), Khosla et al.
patent: 6177262 (2001-01-01), Ziermann et al.
patent: 6200813 (2001-03-01), Katz et al.
patent: 6251636 (2001-06-01), Betlach et al.
patent: 6271255 (2001-08-01), Leadlay et al.
patent: 6274560 (2001-08-01), Khosla et al.
patent: WO 98/41315 (1998-09-01), None
patent: WO 99/05283 (1999-04-01), None
patent: WO 00/026349 (2000-05-01), None
patent: WO 01/27284 (2001-04-01), None
Shah et al. Cloning, Characterization and Heterologous Expression of a Polyketide Synthase and P-450 Oxidase Involved in the Biosynthesis of the Antibiotic Oleandomycin. The Journal of Antibiotics (May, 2000) 53:502-508.*
Mendes et al. Engineered biosynthesis of novel polyenes. Chemistry & Biology (Jul., 2001) 8:635-644.*
Gaisser et al. Parallel pathways for oxidation of 14-membered polyketide macrolactones inSaccharopolyspora erythraea. Molecular Microbiology (2002) 44(3):771-781.*
Molnar et al. Organisation of the biosynthetic gene cluster for rapamycin inStreptomyces hygroscopicus: analysis of genes flanking the polyketide synthase. Gene (1996) 169:1-7.*
Betlach et al., Biochemistry (1998) 37:14937-14942.
Bisang et al., Nature (1999) 401:502-505.
Genbank Accession No. L09654, Apr. 1996.
Haydock et al., Mol. Gen. Genet. (1991) 230:120-128.
Hopwood, Chem. Rev. (1997) 97:2465-2497.
Hu et al., Molecular Microbiology (1994) 14(1):163-172.
Jacobsen et al., Science (1997) 277:367-369.
Kakavas et al., J. of Bacteriology (1997) 179(23):7515-7522.
Kao et al., Science (1994) 265:509-512.
Katz et al., Ann. Rev. Microbiol. (1993) 47:875-912.
Merson-Davies et al., Mol. Microbiol. (1994) 13:349-355.
Olano et al., Mol. Gen. Genet. (1998) 259:299-308.
Oliynyk et al., Chemistry & Biology (1996) 6:833-839.
Patterson et al., CA (1988) 109:129535.
Quiros et al., Mol. Microbiol. (1998) 28:1177-1185.
Rodriguez et al., FEMS Microbiol. Lett. (1995) 127:117-120.
Schwecke et al., PNAS (1995) 92:7839-7843.
Shah et al., CA (2000) 133:291766.
Spagnoli et al., J. Antibiotics (1983) 36:365-375.
Stassi et al., J. Bacteriol. (1993) 175:182-189.
Swan et al., Molec. Gen. Genet. (1994) 242:358-362.
Tang e
Chao Yuan
Favorito Carolyn A.
Kerr Kathleen
Kosan Biosciences, Inc.
LandOfFree
Methods for introducing hydroxyl or epoxide groups into... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for introducing hydroxyl or epoxide groups into..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for introducing hydroxyl or epoxide groups into... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3283057